CANCELL DX Trademark

Trademark Overview

On Thursday, March 24, 2022, a trademark application was filed for CANCELL DX with the United States Patent and Trademark Office. The USPTO has given the CANCELL DX trademark a serial number of 79343154. The federal status of this trademark filing is REGISTERED as of Tuesday, September 5, 2023. This trademark is owned by Angle Europe Limited. The CANCELL DX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and medical research services in the fields of oncology, cancer treatment and diagnosis; medical research services relating to blood and other bodily fluids in the fields of oncology and cancer treatment and diagnosis; bioanalytical testing services in the fields of oncology, cancer treatment and diagnosis for medical research purposes; scientific and medical laboratory services; laboratory testing and analysis for medical research purposes in the fields of oncology and cancer treatment and diagnosis; scientific, technological, and data analysis services, namely, chemical, biochemical, and biological analysis; advice and information relating to the aforesaid services
cancell dx

General Information

Serial Number79343154
Word MarkCANCELL DX
Filing DateThursday, March 24, 2022
Status700 - REGISTERED
Status DateTuesday, September 5, 2023
Registration Number7152928
Registration DateTuesday, September 5, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 20, 2023

Trademark Statements

Pseudo MarkCANCER CELL DIAGNOSIS
Pseudo MarkCAN CELL DX
Disclaimer with Predetermined Text"DX"
Goods and ServicesScientific and medical research services in the fields of oncology, cancer treatment and diagnosis; medical research services relating to blood and other bodily fluids in the fields of oncology and cancer treatment and diagnosis; bioanalytical testing services in the fields of oncology, cancer treatment and diagnosis for medical research purposes; scientific and medical laboratory services; laboratory testing and analysis for medical research purposes in the fields of oncology and cancer treatment and diagnosis; scientific, technological, and data analysis services, namely, chemical, biochemical, and biological analysis; advice and information relating to the aforesaid services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 4, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAngle Europe Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NameAngle Europe Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NameAngle Europe Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Tuesday, January 2, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, December 8, 2023FINAL DISPOSITION NOTICE SENT TO IB
Friday, December 8, 2023FINAL DISPOSITION PROCESSED
Tuesday, December 5, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 5, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 5, 2023REGISTERED-PRINCIPAL REGISTER
Monday, July 3, 2023ASSIGNED TO EXAMINER
Tuesday, June 20, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 20, 2023PUBLISHED FOR OPPOSITION
Sunday, June 18, 2023NOTIFICATION PROCESSED BY IB
Wednesday, May 31, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 31, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 31, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 4, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, May 4, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 4, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, May 4, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, March 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 30, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 30, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, March 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 30, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 9, 2023REFUSAL PROCESSED BY IB
Tuesday, December 20, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, December 19, 2022REFUSAL PROCESSED BY MPU
Friday, October 7, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 6, 2022NON-FINAL ACTION WRITTEN
Monday, September 26, 2022ASSIGNED TO EXAMINER
Tuesday, June 28, 2022APPLICATION FILING RECEIPT MAILED
Friday, June 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 23, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

cancell services medical cancer diagnosis oncology treatment fields research scientific analysis